BioCentury | Sep 26, 2011
Company News

Abnova Corp., Clearbridge BioMedics Pte. Ltd. deal

...tumor cells (CTCs) from blood. Abnova will provide its research- and cGMP clinical-grade antibody reagents. Abnova...
...use in October and for in vitro diagnostic use by 2012. Details were not disclosed. Abnova Corp....
BioCentury | Oct 2, 2006
Company News

Abnova Corp., Axela Biosensors Inc. deal

...and Abnova will co-develop biomarker panels for use on Axela's dotLab protein binding detection system. Abnova...
...antibodies against undisclosed targets selected by Axela. Axela will sell any biomarker panels developed, and Abnova...
...Optics Technology (dot) uses microfluidics and photonics to detect the interactions between molecules and targets. Abnova Corp....
BioCentury | Nov 22, 2004
Company News

Abnova Corp., EMBL deal

...EMBL and Abnova partnered for high throughput production of monoclonal antibodies. The deal combines EMBL's automated...
...of monoclonal antibodies. The deal combines EMBL's automated platform and monoclonal antibody production systems with Abnova's...
...industrial-scale production of recombinant proteins. The partners also may market custom monoclonal antibodies and services. Abnova Corp....
Items per page:
1 - 3 of 3
BioCentury | Sep 26, 2011
Company News

Abnova Corp., Clearbridge BioMedics Pte. Ltd. deal

...tumor cells (CTCs) from blood. Abnova will provide its research- and cGMP clinical-grade antibody reagents. Abnova...
...use in October and for in vitro diagnostic use by 2012. Details were not disclosed. Abnova Corp....
BioCentury | Oct 2, 2006
Company News

Abnova Corp., Axela Biosensors Inc. deal

...and Abnova will co-develop biomarker panels for use on Axela's dotLab protein binding detection system. Abnova...
...antibodies against undisclosed targets selected by Axela. Axela will sell any biomarker panels developed, and Abnova...
...Optics Technology (dot) uses microfluidics and photonics to detect the interactions between molecules and targets. Abnova Corp....
BioCentury | Nov 22, 2004
Company News

Abnova Corp., EMBL deal

...EMBL and Abnova partnered for high throughput production of monoclonal antibodies. The deal combines EMBL's automated...
...of monoclonal antibodies. The deal combines EMBL's automated platform and monoclonal antibody production systems with Abnova's...
...industrial-scale production of recombinant proteins. The partners also may market custom monoclonal antibodies and services. Abnova Corp....
Items per page:
1 - 3 of 3